Related Content

Counseling Patients With Ingrown Toenail

Patients frequently are reluctant to seek professional treatment for this painful condition.

Diabetic Foot Complications

According to the American Diabetes Association (ADA), 60% to 70% of diabetes patients develop peripheral nerve damage.

Management of Acute Diabetic Foot Disease

Diabetic foot disease is a spectrum of disorders involving the cutaneous, soft-tissue, and osseous structures of the foot.

The Link Between Periodontitis and Cardiovascular Disease

Pharmacists can recommend dental intervention and appropriate products to patients.



Antipsychotic Use for Behavioral and Psychological Symptoms of Dementia

During the moderate and late stages of dementia, patients experience behavioral and psychological symptoms of dementia, such as agitation, psychosis, and aggression.

Combining Cervical Cancer Drugs, Chemo to Extend Life 3/19/2014



Nanoparticles Target Cancer-Fighting Immune Cells 3/19/2014



Exhaled Breath May Signal Early Lung Cancer 2/19/2014



Study: Mammography Benefits Younger Women 2/19/2014



The Cardiotoxicity of Cancer-Related Drug Therapies 2/19/2014

Cardiotoxicity, in which the heart muscle is damaged and cannot efficiently pump blood to oxygenate the body’s vital organs, is one of the most prominent morbidities in cancer patients surviving 5 to 10 years post therapy.

Resveratrol Could Help Treat a Variety of Cancer Types 11/15/2013



Omega-3s May Raise Risk of Prostate Cancer 8/20/2013



Gene Mutation’s Link to Aspirin Efficacy in Colorectal Cancer 7/17/2013



Protein and Prostate Cancer Progression 7/17/2013



At-Home Test for Prostate Cancer in Development 6/21/2013



Selumetinib Promising Against Ovarian Cancer 3/20/2013



Cancer Cells Exploit Immune Response to Survive 1/23/2013



Iclusig Approved to Treat Two Forms of Leukemia 1/23/2013



Overview of Pancreatic Cancer 12/19/2012

Pancreatic cancer is a devastating and lethal disease affecting one in 68 Americans.


Daily Multivitamins Reduce Risk of Cancer in Men 11/20/2012



Routine PSA Tests Not Recommended 6/20/2012



Paternal Genes Linked to Early Breast Cancer 1/20/2012



Possible Leukemia Cure Found in Fish Oil 1/20/2012



Avastin’s Breast Cancer Indication Revoked 12/20/2011



Therapeutic Agents in Osteosarcoma 10/19/2011

Novel agents are being investigated to achieve a better therapeutic outcome and a reduction in adverse events. 

HercepTest for the Detection of HER2 Protein Overexpression in Breast and Gastric Cancers 9/20/2011

This assay helps determine whether trastuzumab treatment may be considered. 

Some Herbal Supplements May Adversely Affect Chemotherapy 9/20/2011



Avastin’s Breast Cancer Indication May Be Pulled 8/19/2011



ACS Reports on Cancer Mortality 7/20/2011



Bladder Cancer: A Review 6/20/2011

In 2010, the urinary bladder was the fourth most common site of new cancer cases in the United States, with an estimated 70,530 new cases and 14,680 deaths.

Coffee May Lower Risk of Prostate Cancer 6/20/2011



Compound Prevents Prostate Cancer Cell Growth 1/20/2011



New Late-Stage Breast Cancer Treatment Approved 12/17/2010



Capsaicin Linked to Skin Cancer 10/20/2010



View Full Article

Hodgkin’s Lymphoma 10/20/2010

Lymphoma is a form of cancer that affects the lymphatic system, a part of the body’s immune system that helps fight infection.

Increasing Selenium May Reduce Bladder Cancer Risk 10/20/2010



Low-Dose Aspirin Protects Against Bowel Cancer 10/20/2010



Metastatic Melanoma Treatment Fast Tracked 10/20/2010



Therapy Effective Against Aggressive Thyroid Cancer 10/20/2010



TOP2A FISH pharmDx Kit: A Tool for Assessing Breast Cancer Prognosis 9/20/2010

This kit is a tool for use in assessing the clinical course of breast cancer and response to therapy in certain patients with the disease.


Clinical Evidence That Anticancer Drug Triggers Viral Infection 5/20/2010



Coffee Could Protect Against Diabetes, Prostate Cancer 1/20/2010



Colorectal Cancer Screening 12/17/2009

Routine examinations, beginning at age 50, are key to preventing this disease and saving lives.


View Full Article

Newly Approved mTOR Inhibitors for the Treatment of Metastatic Renal Cell Carcinoma 11/19/2009

Temsirolimus and everolimus are now indicated as therapy for this type of cancer.


Prostate Cancer May Cause Neglect of Other Diseases 2/20/2009



Breast Tumor Characteristics Predict Contralateral Disease 2/20/2009



Targeted Therapy with Tyrosine Kinase Inhibitors 10/17/2008

ABSTRACT: Tyrosine kinases are a family of proteins that contribute to the development of cancer.

Thalidomide: New Cancer Uses for an Old Drug 7/18/2008

ABSTRACT: Thalidomide, a drug once thought to have no clinical benefit due to its significant toxicity, has now become a potential agent for the treatment of hematologic malignancies and some solid tumors.

Drug Combination Slows Prostate Cancer Growth 7/18/2008

Attendees at a meeting of the American Association for Cancer Research learned that while the results of a study conducted at Rutgers University in New Brunswick, NJ, showed that atorva­ statin (Lipitor) and celecoxib (Celebrex) individually slowed tumor progression from androgen-dependent to androgen-independent status, the two drugs combined had additive growth-inhibiting activity compared with either drug alone.

Anticoagulation Management in Patients with Cancer 7/18/2008

ABSTRACT: Cancer, chemotherapy, and surgery are conditions that increase the risk of the development of venous thromboembolism (VTE), a common and potentially life-threatening condition.

Can NSAIDs Play a Role in Preventing Cancer? 5/20/2008

Researchers at the National Sun Yat-Sen University and Kaohsiung Medical University in Taiwan say they've uncovered a mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) attenuate tumor invasion and metastasis, leading them to think that NSAIDs may be a novel class of effective chemopreventive drugs.

NSAIDs May Play Role in Reducing Breast Cancer 4/18/2008

Researchers at London's Guy's Hospital said that aspirin and similar non-steroidal anti-inflammatory drugs (NSAIDs) could reduce breast cancer by up to 20%.

The Third-Generation Aromatase Inhibitors 4/18/2008

Adverse effects of AIs include cardiovascular dysfunction such as hypertension, vasodilation, edema, and chest pain.

Goals of Therapy for Multiple Myeloma 4/18/2008

ABSTRACT: Multiple myeloma accounts for approximately 1% of new cancer diagnoses in the United States each year.

Skin Cancer 4/18/2008

ABSTRACT: Skin, the largest organ in the human body, has several functions, including protection from mechanical, thermal, and environmental impact.

Patterns in Sun-Protection Behaviors 4/18/2008

Between 1975 and 2004 the number of new cases of melanoma rose, and it is estimated that 60,000 new cases occurred in 2007.

Iris BioTechnologies Introduces Nano-Biochip for Breast Cancer 3/20/2008

Iris BioTechnologies focuses on diagnostic therapy for individual patients based on their genomic profile.

A Review of Tumor Lysis Syndrome  3/10/2008

ABSTRACT: Tumor lysis syndrome (TLS), an oncologic emergency, results when cancer cells are rapidly lysed after chemotherapy or other treatments.

Osteosarcoma and Dose-Intensive Chemotherapy 3/10/2008

ABSTRACT: The frequency of bone cancer is very rare, with only 400 to 700 new cases diagnosed annually.

Cancer Continues Its Deadly Track 2/20/2008

According to a report from the American Cancer Society, 12 million new cases of malignancy were diagnosed worldwide in 2007; this translates to 7.6 million people dying from the disease.

Fewer Children Are Dying from Cancer 2/20/2008

Despite a 0.6% increase in pediatric malignancies, The Centers for Disease Control and Prevention said that fewer children are dying from cancers. In a report by Loria Pollack, MD, and colleagues that was published in Mortality and Morbidity Weekly Report, the researchers stated that the lower pediatric mortality rate of cancer in the U.S. "likely reflects advances in cancer treatment in this population."

Focus on Phytoestrogens 12/20/2007

Phytoestrogens are trace biochemicals produced by plants that act like estrogens in animal cells and bodies.

Enhancing Patient Adherence to Improve Outcomes With Oral Chemotherapy 10/18/2007

The post-test exam and post-activity evaluation form are available at www.

Cancer News 10/18/2007

Key Myeloma Mechanism Discovered In a discovery that might lead to a greater understanding of how multiple myeloma starts and how to best treat the disease, researchers from the National Cancer Institute (NCI)  have identified changes to molecules in cancer cells that activate the NF-kappaB signaling pathway, which has an important role in cancer cell growth and survival.

Hormonal Therapies in Breast and Prostate Cancers 10/18/2007

ABSTRACT: In the United States, breast cancer and prostate cancer are the most common types of cancer diagnosed in women and men, respectively.

Many Women on Oral Contraceptives Not at Overall Risk for Cancer 10/18/2007

According to a study done at the University of Aberdeen, Scotland, there is good news for women who take oral contraceptives for eight or fewer years.

Targeted Therapies for NSCLC 10/18/2007

ABSTRACT: Non–small cell lung cancer (NSCLC) continues to be the leading cause of cancer death in the United States, and treatment for patients with advanced NSCLC remains an important, clinically complex challenge.

Cancer/AIDS News 7/13/2007

Childhood Cancer Survivors Have Higher Health Risks as Adults While more effective treatments for childhood cancers have dramatically improved survival rates, children who had been treated for cancer could to be at a higher risk of health problems as adults.

Management of Chronic Myelogenous Leukemia 7/13/2007

ABSTRACT: Chronic myelogenous leukemia (CML) is a hematologic malignancy associated with chromosomal abnormalities, including the Philadelphia chromosome (Ph).

Prostate Cancer: Focus on Therapeutic Vaccines 7/13/2007

ABSTRACT: Therapeutic cancer vaccines differ from traditional vaccines in that they are only given to patients who already have cancer, with the goal of decreasing the spread of the disease and prolonging survival.

Therapeutic Approaches to Coagulopathy in Cancer Patients 7/13/2007

ABSTRACT: In the United States, it is estimated that the frequency of venous thromboembolism (VTE) among cancer patients is approximately 1 in 200.

Clinical News Digest 7/13/2007

ED Drugs May Have Other Benefits Studies recently presented at the American Urological Association meeting point to the fact that type 5 phosphodiesterase (PDE5) inhibitors used in the treatment of erectile dysfunction (ED) may be effective against benign prostatic hyperplasia (BPH) and lower urinary tract symptoms.

Clinical News Digest 6/19/2007

Regular Aspirin Use Reduces Risk of Colon Cancer

Chemotherapy-Induced Anemia in Patients with Cancer 4/17/2007

Erythropoiesis, or the production of erythrocytes (i.

Topical of Imiquimod 5% Cream in Organ Transplant Recipients 4/17/2007

Skin cancer occurrence in organ transplant recipients (OTRs) is a rising phenomenon.

Chemotherapy for Prostate Cancer 4/17/2007

Prostate cancer is the most common solid tumor affecting men in the United States.

A New Era of Anticoagulation  3/21/2007

Thromboembolism is one of the leading causes of morbidity and mortality in the United States.

Future Technology for Warfarin Dosing 3/21/2007

Blood clotting is a very complicated process.

Cancer/AIDS News 3/21/2007

Circumcision Reduces HIV Transmission Two studies in the Lancet bring the number of studies establishing a strong link between circumcision and a reduction in the risk of HIV transmission to three.

Clinical News Digest 1/23/2007

Body Fluid Displacement Can Lead to Sleep Apnea

Cancer News 1/23/2007

Breast Cancer Patients May Benefit from Second Opinion

A Review of the 2006 ASCO Antiemetic Guidelines Update 1/23/2007

ABSTRACT: Emesis as an adverse event of antineoplastic therapy can be troublesome for many oncology patients.

A Review of Renal Cell Carcinoma 1/23/2007

In the United States, kidney cancer (renal cell carcinoma) is estimated to be the seventh most common cancerous condition diagnosed in men and the 13th most common in women, accounting for 2.7% of all malignant conditions.

Advertisement